Interventional Cardiology Devices Market: Growth, Size, Share, and Trends

Report Code MD 3456
Published in Dec, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Interventional Cardiology Devices Market by Type (Stents, Structural Heart Devices, Angioplasty Balloons (Drug-Eluting), Angiography Catheters, Plaque Modification Devices (Thrombectomy Devices), Guidewires, Introducer Sheaths) - Global Forecast to 2029

Overview

The global interventional cardiology devices market is projected to reach USD 27.80 billion in 2024 and is projected to reach USD 37.27 billion by 2029, at a CAGR of 6.0% during the forecast period. The growth in the interventional cardiology devices market is mainly due to an increase in CVDs across the world, the aging population, and the growing prevalence of risk factors like diabetes, hypertension, obesity, and sedentary lifestyle. Improvements in technology, such as the advent of bioresorbable stents, drug-eluting stents, and imaging systems, are significantly enhancing procedural efficacy and patient outcomes, thereby making interventional cardiology more accessible and appealing. The emigrant economies are also modernizing health care infrastructure, and favourable governmental policies along with investments in healthcare systems have been fuelling the growth of the market for interventional cardiology devices. Besides, the preference of patients for less invasive procedures that have shorter hospital stays, and a faster recovery time is also boosting demand.

Interventional Cardiology Devices Market

Attractive Opportunities in the Interventional Cardiology Devices Market

Asia Pacific

The growth in interventional cardiology devices in the Asia-Pacific APAC region is driven by a combination of factors. Rapid urbanization, coupled with lifestyle changes, has been increasing cardiovascular diseases across countries such as China, India, and Japan.

The growth of interventional cardiology devices is fueled by several factors. These include, among others, the increasing incidence of cardiovascular diseases, often associated with aged population demographics, unhealthy lifestyles, and high rates of hypertension and diabetes, which require advanced treatments for cardiovascular conditions.

The interventional cardiology device market is expanding at a very high pace in emerging economies. Such countries as those in Asia-Pacific, Latin America, and parts of the Middle East are witnessing an increased demand for these devices due to the increasing cases of cardiovascular diseases, increased awareness of advanced treatment options, and increased healthcare spending.

The European interventional cardiology devices market is projected to reach USD 9.3 billion by 2029, growing at a CAGR of 5.0% during the forecast period.

Stringent regulatory requirements delaying the approval of cardiac devices is expected to challenge to the market growth.

Global Interventional Cardiology Devices Market Dynamics

DRIVER: Growing prevalence of cardiovascular diseases

The rising incidence of CVDs is one of the primary drivers that are driving the interventional cardiology market forward. Coronary artery disease, myocardial infarctions, and heart failure are some of the most common CVDs, which have risen exponentially with factors such as sedentary lifestyles, unhealthy diets, and the aging population. Advanced treatments for these conditions often call for interventional cardiology procedures that can offer solutions in a minimally invasive fashion.

Given the increasing burden of CVDs worldwide, early intervention and appropriate treatment forms have gained prominence in healthcare systems. Development and use of more interventional cardiology devices such as stents, catheters, and balloon angioplasty systems are growth drivers in this market.

RESTRAINT: Availability of alternative treatments

Alternative methods that avoid invasiveness have been a constant rise in the interventional cardiology market. In this case, pharmacological advancements have brought into being drugs that have proven effective - most especially the anticoagulants and lipid-lowering agents. Such drugs can effectively treat conditions like atherosclerosis and hypertension and even prevent interventions like angioplasty from being conducted. Lifestyle interventions- diet changes, exercise programs, smoking-cessation support- are gaining traction for their cardiovascular benefits. Emerging noninvasive technologies, such as more sensitive imaging techniques and more portable health monitors, would permit earlier detection and tracking and could reduce the rates of interventional procedures. This may provide alternative, less-invasive options for patients; in this case, managing cardiovascular disease would be a more preventative approach, thereby modulating growth in the sector of interventional cardiology.

 

OPPORTUNITY: High growth potential in emerging markets

The merging markets hold significant growth potential in the interventional cardiology market due to increased access to healthcare, rising awareness of cardiovascular diseases, and improvement in medical infrastructure. Several geographies, such as the Asia-Pacific, Latin America, and parts of the Middle East, are experiencing fast-paced urbanization and economic growth, which is often associated with lifestyle-related diseases, including cardiovascular conditions. Intervening cardiology carries very attractive prospects of being more in demand due to increased demands brought on by aging populations and heart diseases. Not to mention this, the governments in this region are concerned about advancing the health care sector and adopting all positive policies toward it and pumping in more funds toward medical technology development. This evolving landscape of interventional cardiology will present huge opportunities for expansion and further penetration for companies, further interaction with local healthcare services, and introduction of new product and treatments, which will consequentially enhance the growth rates in the market.

CHALLENGES: Stringent regulatory requirements delaying the approval of cardiac devices

Interventional cardiology is very significantly challenged by strict regulatory requirements for medical devices. Strict regulations are a means to the end of the safety, efficacy, and quality of devices used for the treatment of cardiovascular diseases, often involving some risk factor. Again, time and money are lost by manufacturers while trying to achieve these standards. Approval processes usually carry out long clinical trials, are very documentative, and need to comply with international standards, which delays product launching and increases research and development costs.

In addition, since the regulations keep updating, companies have to regularly update their processes and products to maintain compliance, where this will be a serious issue for smaller companies with limited resources. Regulatory complexity creates entry barriers and may stifle innovation. Ultimately, that will influence the speed with which new interventional cardiology solutions reach the market.

Global Interventional Cardiology Devices Market Ecosystem Analysis

The interventional cardiology devices market ecosystem involves various stakeholders and technologies. Cleanroom equipment manufacturers are Central to the system, supplying HVAC systems, HEPA filters, laminar airflow systems, and other systems. Such systems are essential in the appropriate functioning of controlled environments required by pharmaceuticals, biotechnology, and electronics industries. Other primary players include component suppliers of specialized materials such as filtration membranes, air diffusers, and cleanroom furniture.

Interventional Cardiology Devices Market
 

Angioplasty Stents segment to lead interventional cardiology devices market during forecast period

The largest growth rate in the interventional cardiology market will be found in the segment of angioplasty stents. This is largely due to a huge surge in rates of cardiovascular diseases all around the world as well as advancements in technology in terms of stent provision with better outcomes in patients. Stents, particularly drug-eluting and bioresorbable varieties, are increasingly favored since they significantly reduce the risk of restenosis due to arterial reblockage and other complications. As minimalism becomes the new normal and more invasive procedures, people are opting for minimally invasive procedures as their go-to option, so therefore, angioplasty stents are the new normal offering a reliable less-invasive alternative to surgery thereby adding to their demand. It is also being said that growing investments in R and D have led to better innovative designs of stent, thereby expanding the markets further.

Thrombectomy devices segment to record highest growth during forecast period

Thrombectomy devices are expected to grow the most in the interventional cardiology market. This is because of the increased incidence of cardiovascular diseases, specifically acute ischemic events, such as heart attacks and strokes, where the need for rapid removal of blood clots is critical. Improvements in device design, such as enhanced aspiration catheters and mechanical clot retrievers, have improved procedural success rates and patient outcomes. Additionally, the increasing awareness and adoption of minimally invasive techniques are driving the use of thrombectomy over traditional surgical methods. As hospitals and healthcare providers focus on improving acute intervention capabilities, the demand for thrombectomy devices is likely to increase, making it a major growth driver in interventional cardiology.

End user hospitals to dominate interventional cardiology devices market during forecast period

The largest interventional cardiology market share is expected from hospitals because of the ever-increasing population suffering from cardiovascular diseases, which will necessitate greater demand for the minimally invasive treatment procedures. Further, improvement in interventional technologies also allows hospitals to provide wide-ranging specialized services, for example, advanced coronary and structural heart interventions. Along with it, hospital-based catheterization labs as well as specialized cardiac centers are established all over the world. With the surge in huge investments in the health care infrastructures and because of a surge in the population of professional cardiologists; the number of hospitals increasing its shares in the overall market, acting as an important and primary center conducting risky processes, which tends to help increase the proportion in this interventional cardiology market and is believed to represent a major contributing factor in their growth.

North America to be fastest–growing region during forecast period

North America is most likely to grow in interventional cardiology diseases, where the prevalence of cardiovascular disease is increasing, and healthcare systems are well established, alongside the development of medical technology. The region benefits greatly from a high adoption rate of innovative procedures, which include minimally invasive interventions and catheter-based treatments contributing to improved patient outcomes and quicker recovery times. Besides, high expenditure on R&D, along with an aging population, is fueling demand for interventional cardiology products. Government initiatives to increase access to healthcare and health-conscious lifestyles are increasing in North America, which is driving the market in the region. The region continues to focus on enhancing cardiovascular care, which will make it the growth leader in the market over the coming years.

HIGHEST CAGR MARKET IN 2023
ASIA_PACIFIC FASTEST GROWING MARKET IN THE REGION
Interventional Cardiology Devices Market

Recent Developments of Interventional Cardiology Devices Market

  • In September 2024, Boston Scientific Corporation has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSE Pulsed Field Ablation (PFA) System. The FARAPULSE PFA System, which is indicated for the isolation of pulmonary veins in the treatment of paroxysmal atrial fibrillation (AF), is a novel alternative to standard-of-care thermal ablation treatment.
  • In September 2024, Medtronic plc, the global leader in medical technology, announced the launch of a new ECMO system called VitalFlow, which is a configurable one-system ECMO solution, built on simplicity and performance. The vitalflow ECMO system bridges the gap between bedside care and intra-hospital transport, offering physicians and clinicians an easier, smarter ECMO experience.
  • In July 2024, Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since that time, Innovalve has demonstrated progress in its program with promising early clinical experience.
  • In February 2024, Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).

Key Market Players

KEY PLAYERS IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Interventional Cardiology Devices Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD)
Segments covered Interventional cardiology devices – Angioplasty Stents, Structural Heart Devices, Catheters, Angioplasty Balloons, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Other Devices, End user and Region
Geographies covered Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa.

 

Key Questions Addressed by the Report

Which is the largest segment of the interventional cardiology devices market by product?
The angioplasty stent segment is expected to drive market growth based on product type. The rising prevalence of cardiovascular diseases, aging population, sedentary lifestyle, and obesity contribute to the high demand for stent procedures. Improvements in stent design, such as bioresorbable and drug-eluting stents, enhance safety and outcomes, encouraging both physicians and patients.
Which is the largest segment of the interventional cardiology devices market by catheters type?
The angiography catheters segment holds the largest share in the interventional cardiology devices market. The increasing prevalence of cardiovascular diseases, such as coronary artery disease, boosts the demand for diagnostic and interventional procedures that require angiography catheters. Improvements in catheter design technology enhance the precision and safety of imaging for healthcare providers.
Which is the largest segment of the interventional cardiology devices market by hemodynamic flow alteration device type?
The embolic protection devices segment holds the largest share in the interventional cardiology devices market. The rising prevalence of cardiovascular diseases and the increase in minimally invasive procedures drive the demand for embolic protection to prevent strokes during coronary interventions.
Which is the largest segment of the interventional cardiology devices market by plaque modification device type?
The thrombectomy devices segment holds the largest share in the interventional cardiology devices market. The growing prevalence of cardiovascular diseases such as acute ischemic stroke, pulmonary embolism, and deep vein thrombosis drives the demand for effective clot removal solutions. Technological advancements have made thrombectomy devices more effective, minimally invasive, and safe, leading to increased adoption.
Which is the largest segment of the interventional cardiology devices market by end user?
The hospitals segment has the largest share of the market and is expected to drive segment growth. The increasing prevalence of cardiovascular diseases and the demand for complex procedures like angioplasty, stenting, and atherectomy, which require specialized hospital settings with advanced imaging technologies and trained professionals, contribute to this growth.
Which country/region occupies the largest interventional cardiology devices market share globally?
North America occupies the largest share of the market in 2023. Factors driving market growth in this region include the aging population, high prevalence of cardiovascular diseases, and increased demand for minimally invasive procedures. Advances in stent technologies, imaging, and a strong healthcare infrastructure also contribute to market expansion.

 

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Interventional Cardiology Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
29
RESEARCH METHODOLOGY
34
EXECUTIVE SUMMARY
50
PREMIUM INSIGHTS
56
MARKET OVERVIEW
60
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing prevalence of cardiovascular diseases
    - Rising technological investments in interventional cardiology procedures
    - Increasing prevalence of diabetes
    - Favorable regulatory support
    RESTRAINTS
    - Availability of alternative treatments
    - Product recalls
    OPPORTUNITIES
    - High growth potential in emerging markets
    - Increasing demand for coronary stents
    CHALLENGES
    - Stringent regulatory requirements for product approvals
  • 5.3 INDUSTRY TRENDS
    DRUG-ELUTING TECHNOLOGIES
    INCREASING EMPHASIS ON MINIMALLY INVASIVE PROCEDURES
  • 5.4 SUPPLY CHAIN ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - TAVR technology
    ADJACENT TECHNOLOGIES
    COMPLEMENTARY TECHNOLOGIES
    - Integration of real-time monitoring into wearable technologies
    - Precise cardiovascular interventions through artificial intelligence
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - North America
    - Europe
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 PRICING ANALYSIS
    INDICATIVE AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT TYPE, 2023
    INDICATIVE AVERAGE SELLING PRICE OF INTERVENTIONAL CARDIOLOGY DEVICES, BY PRODUCT TYPE, 2023
    INDICATIVE AVERAGE SELLING PRICE, BY REGION
  • 5.10 ECOSYSTEM ANALYSIS
  • 5.11 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR INTERVENTIONAL CARDIOLOGY DEVICES
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.12 TRADE ANALYSIS
    TRADE ANALYSIS FOR INTERVENTIONAL CARDIOLOGY DEVICES AND CONSUMABLES
    HS CODES
  • 5.13 KEY CONFERENCES & EVENTS, 2024−2025
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.15 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.16 IMPACT OF AI/GEN AI ON INTERVENTIONAL CARDIOLOGY DEVICES MARKET
  • 5.17 CASE STUDY ANALYSIS
    CASE STUDY 1: BOSTON SCIENTIFIC CORPORATION USES GUIDEZILLA II EXTENSION CATHETER FOR PC INTERVENTIONS
    CASE STUDY 2: MEDTRONIC PROVIDES CARDIOLOGY DEVICES FOR VENOUS INTERVENTIONS
  • 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.19 ADJACENT MARKETS FOR INTERVENTIONAL CARDIOLOGY DEVICES
  • 5.20 INVESTMENT & FUNDING SCENARIO
ANGIOPLASTY STENTS MARKET, BY TYPE
100
  • 6.1 INTRODUCTION
    DRUG-ELUTING STENTS
    - Drug-eluting stents to hold largest share of angioplasty stents market
    BARE-METAL STENTS
    - Increasing use of drug-eluting stents to limit growth of bare-metal stents market
    BIOABSORBABLE STENTS
    - Ability of bioabsorbable stents to ensure complete healing of arteries to propel demand
STRUCTURAL HEART DEVICES MARKET, BY TYPE
109
  • 7.1 INTRODUCTION
    AORTIC VALVE THERAPY DEVICES
    - Increasing prevalence of aortic valve stenosis to support market growth
    OTHER THERAPY DEVICES
CATHETERS MARKET, BY TYPE
116
  • 8.1 INTRODUCTION
    ANGIOGRAPHY CATHETERS
    - Rising cases of artery disease and heart attacks to propel market
    GUIDING CATHETERS
    - Increasing number of angiography procedures to drive the market
    IVUS/OCT CATHETERS
    - Ability to obtain 3D images for aneurysm assessment to support market growth
ANGIOPLASTY BALLOONS MARKET, BY TYPE
126
  • 9.1 INTRODUCTION
    OLD/NORMAL BALLOONS
    - Low treatment costs associated with old/normal balloons to drive growth
    DRUG-ELUTING BALLOONS
    - Rising number of regulatory approvals for drug-eluting balloons to support market growth during forecast period
    CUTTING/SCORING BALLOONS
    - Limited use of cutting balloon-aided procedures to restrain market growth
PLAQUE MODIFICATION DEVICES MARKET, BY TYPE
134
  • 10.1 INTRODUCTION
    THROMBECTOMY DEVICES
    - Ability to remove blood clots in STEMI and NSTEMI patients to propel market
    ATHERECTOMY DEVICES
    - Increasing use of lipid-modifying drugs for atherosclerosis to support market growth
HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE
140
  • 11.1 INTRODUCTION
    EMBOLIC PROTECTION DEVICES
    - Adoption of filter & occlusion-based devices to propel market
    CHRONIC TOTAL OCCLUSION DEVICES
    - Uptake in treatment of total occlusions to drive market
OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE
145
  • 12.1 INTRODUCTION
    GUIDEWIRES
    - Growing demand for stent placements and coronary intervention procedures to propel market
    VASCULAR CLOSURE DEVICES
    - Ability to provide increased efficacy in patient outcomes to fuel uptake
    INTRODUCER SHEATHS
    - Ability to provide secure access to blood vessels to support market growth
    BALLOON INFLATION DEVICES
    - Increasing incidence of peripheral artery disease to drive market
    HEMOSTASIS HEART VALVES
    - Growing focus on precision medicine
INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER
154
  • 13.1 INTRODUCTION
  • 13.2 HOSPITALS
    AVAILABILITY OF ADVANCED INFRASTRUCTURE AND SPECIALIZED EQUIPMENT TO DRIVE MARKET
  • 13.3 AMBULATORY SURGERY CENTERS
    LOW CASES OF HAIS AND SHORTER RECOVERY TIMES TO PROPEL MARKET
  • 13.4 OTHER END USERS
INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION
160
  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Availability of reimbursements for cardiology procedures to drive market
    CANADA
    - Rising prevalence of chronic diseases to drive market
  • 14.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Growing hub for advanced technology product distributors to drive market
    FRANCE
    - Favorable government initiatives in France to support market growth
    UK
    - Growing focus on personalized medicine to fuel uptake
    ITALY
    - Increasing cases of obesity and CVD to support market growth
    SPAIN
    - Increasing prevalence of age-related CVD conditions to drive market
    REST OF EUROPE
  • 14.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - High tobacco consumption and increasing cases of CVD to fuel uptake
    JAPAN
    - Increasing demand for stents and catheters to support market growth
    INDIA
    - Improvements in angioplasty devices to fuel uptake
    AUSTRALIA
    - Increasing cases of lifestyle disorders to support market growth
    SOUTH KOREA
    - Growth in pharmaceutical sectors to propel market
    REST OF ASIA PACIFIC
  • 14.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Rising demand for quality treatment and focus on growing healthcare infrastructure to drive market
    MEXICO
    - Increasing cases of diabetes to fuel market
    REST OF LATIN AMERICA
  • 14.6 MIDDLE EAST & AFRICA
    MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
262
  • 15.1 OVERVIEW
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN INTERVENTIONAL CARDIOLOGY DEVICES MARKET
  • 15.3 REVENUE ANALYSIS
  • 15.4 MARKET SHARE ANALYSIS
  • 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
  • 15.6 COMPANY FOOTPRINT
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Product footprint
    - Angioplasty stents footprint
    - Structural heart devices footprint
    - Catheters footprint
    - Angioplasty balloons footprint
    - Plaque modification devices footprint
    - Hemodynamic flow alteration devices footprint
    - Other interventional cardiology devices footprint
    - End-user footprint
  • 15.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 15.8 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 15.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 15.10 R&D ASSESSMENT OF KEY PLAYERS
  • 15.11 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
COMPANY PROFILES
293
  • 16.1 KEY PLAYERS
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MEDTRONIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Products offered
    - Recent developments
    TERUMO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    EDWARDS LIFESCIENCES CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    B. BRAUN SE
    - Business overview
    - Products offered
    - Recent developments
    INTEGER HOLDINGS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    TELEFLEX INCORPORATED
    - Business overview
    - Products offered
    - Recent developments
    PENUMBRA, INC.
    - Business overview
    - Products offered
    - Recent developments
    COOK
    - Business overview
    - Products offered
    - Recent developments
    CORDIS
    - Business overview
    - Products offered
    - Recent developments
    IVASCULAR S.L.U.
    - Business overview
    - Products offered
    BIOSENSORS INTERNATIONAL GROUP, LTD.
    - Business overview
    - Products offered
    - Recent developments
    BIOTRONIK SE & CO. KG
    - Business overview
    - Products offered
    - Recent developments
  • 16.2 OTHER PLAYERS
    AMG INTERNATIONAL (SUBSIDIARY OF Q3 MEDICAL)
    ENDOCOR GMBH & CO. KG
    INSITU TECHNOLOGIES, INC.
    MERIL LIFE SCIENCES PVT. LTD
    ALVIMEDICA
    CARDIONOVUM GMBH
    MEDINOL
    WELLINQ
    BALTON SP.
    TRANSLUMINA
APPENDIX
358
  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 3 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: STUDY ASSUMPTIONS
  • TABLE 4 RISK ASSESSMENT ANALYSIS: INTERVENTIONAL CARDIOLOGY DEVICES MARKET
  • TABLE 5 GLOBAL ANNUAL CARDIAC SURGICAL VOLUMES PER 100,000 POPULATION (2023)
  • TABLE 6 DIABETIC POPULATION, BY REGION, 2019 VS. 2030
  • TABLE 7 KEY COMPANIES INVOLVED IN PROVIDING DRUG-ELUTING TECHNOLOGIES
  • TABLE 8 BENEFITS OF TAVR OVER SAVR: PATIENT'S PERSPECTIVE
  • TABLE 9 COMPANIES PROVIDING FFR TECHNOLOGIES
  • TABLE 10 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 INDICATIVE AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE
  • TABLE 17 INDICATIVE AVERAGE SELLING PRICE OF INTERVENTIONAL CARDIOLOGY DEVICES, BY REGION, 2023
  • TABLE 18 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: ROLE IN ECOSYSTEM
  • TABLE 19 LIST OF PATENTS/PATENT APPLICATIONS IN THE INTERVENTIONAL CARDIOLOGY DEVICES MARKET, 2021–2023
  • TABLE 20 IMPORT DATA FOR INTERVENTIONAL CARDIOLOGY DEVICES, BY COUNTRY (2023)
  • TABLE 21 EXPORT DATA FOR INTERVENTIONAL CARDIOLOGY DEVICES, BY COUNTRY (2023)
  • TABLE 22 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 END USERS
  • TABLE 24 KEY BUYING CRITERIA FOR TOP 3 END USERS
  • TABLE 25 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 26 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: IMPACT OF GEN AI
  • TABLE 27 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 28 ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 29 ANGIOPLASTY STENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 DRUG-ELUTING ANGIOPLASTY STENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 DRUG-ELUTING ANGIOPLASTY STENTS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 32 BARE-METAL ANGIOPLASTY STENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 BARE-METAL ANGIOPLASTY STENTS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 34 BIOABSORBABLE ANGIOPLASTY STENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 36 STRUCTURAL HEART DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 AORTIC VALVE THERAPY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 AORTIC VALVE THERAPY DEVICES MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 39 OTHER THERAPY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 OTHER THERAPY DEVICES MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 41 CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 42 CATHETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 ANGIOGRAPHY CATHETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 ANGIOGRAPHY CATHETERS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 45 GUIDING CATHETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 GUIDING CATHETERS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 47 IVUS/OCT CATHETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 IVUS/OCT CATHETERS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 49 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 50 ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 52 DRUG-ELUTING ANGIOPLASTY BALLOONS MARKET, BY COUNTRY,2022–2029 (USD MILLION)
  • TABLE 53 DRUG-ELUTING ANGIOPLASTY BALLOONS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 54 CUTTING/SCORING ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 56 PLAQUE MODIFICATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 57 PROCEDURE DATA FOR PLAQUE MODIFICATION DEVICES, BY REGION, 2023 (MILLION)
  • TABLE 58 THROMBECTOMY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 59 ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 61 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 OTHER DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 65 OTHER DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 GUIDEWIRES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 INTRODUCER SHEATHS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 BALLOON INFLATION DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 HEMOSTASIS HEART VALVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 72 INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 INTERVENTIONAL CARDIOLOGY DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 78 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 79 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 81 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 85 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 86 US: MACROECONOMIC INDICATORS
  • TABLE 87 US: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 88 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 89 US: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 US: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 92 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 93 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 95 US: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 96 CANADA: MACROECONOMIC INDICATORS
  • TABLE 97 CANADA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 98 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 99 CANADA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 100 CANADA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 101 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 104 CANADA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 105 CANADA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 106 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 108 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 109 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 EUROPE: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 112 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 113 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 EUROPE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 115 EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER,2022–2029 (USD MILLION)
  • TABLE 116 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 117 GERMANY: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 119 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 120 GERMANY: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 123 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 124 GERMANY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 125 GERMANY: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 126 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 127 FRANCE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 128 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 130 FRANCE: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 131 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 132 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 FRANCE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 135 FRANCE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 136 UK: MACROECONOMIC INDICATORS
  • TABLE 137 UK: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 138 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 139 UK: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 UK: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 142 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 UK: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 145 UK: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 146 ITALY: MACROECONOMIC INDICATORS
  • TABLE 147 ITALY: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 148 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 ITALY: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 ITALY: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 151 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 ITALY: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 155 ITALY: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 156 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 157 SPAIN: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 158 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 160 SPAIN: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 163 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 SPAIN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 SPAIN: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 166 REST OF EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 167 REST OF EUROPE; ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 168 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 REST OF EUROPE: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 170 REST OF EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,2022–2029 (USD MILLION)
  • TABLE 171 REST OF EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 REST OF EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 REST OF EUROPE: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 174 REST OF EUROPE: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 176 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 181 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 183 ASIA PACIFIC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 185 CHINA: MACROECONOMIC INDICATORS
  • TABLE 186 CHINA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 187 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 188 CHINA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 189 CHINA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 190 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 191 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,2022–2029 (USD MILLION)
  • TABLE 192 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,2022–2029 (USD MILLION)
  • TABLE 193 CHINA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 194 CHINA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 195 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 196 JAPAN: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 197 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 198 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 199 JAPAN CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 200 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 201 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 202 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 203 JAPAN: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 204 JAPAN: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 205 INDIA: MACROECONOMIC INDICATORS
  • TABLE 206 INDIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 207 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 208 INDIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 209 INDIA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 210 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 211 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 212 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 213 INDIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 INDIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 215 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 216 AUSTRALIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 217 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 218 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 219 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 220 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 221 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 222 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 223 AUSTRALIA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 224 AUSTRALIA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 225 SOUTH KOREA: MACROECONOMIC INDICATORS
  • TABLE 226 SOUTH KOREA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 227 SOUTH KOREA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 228 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 229 SOUTH KOREA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 230 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 231 SOUTH KOREA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 232 SOUTH KOREA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 233 SOUTH KOREA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 234 SOUTH KOREA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 235 REST OF ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 236 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 237 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 238 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 239 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 240 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 241 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 242 REST OF ASIA PACIFIC: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 243 REST OF ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 244 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 245 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 246 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 247 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 248 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 249 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 250 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 252 LATIN AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 253 LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 254 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 255 BRAZIL: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 256 BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 257 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 258 BRAZIL: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 260 BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 261 BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 262 BRAZIL: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 263 BRAZIL: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 264 MEXICO: MACROECONOMIC INDICATORS
  • TABLE 265 MEXICO: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 MEXICO: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 MEXICO: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 270 MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 271 MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 MEXICO: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 273 MEXICO: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 274 REST OF LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 277 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 278 REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,2022–2029 (USD MILLION)
  • TABLE 279 REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 281 REST OF LATIN AMERICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 282 REST OF LATIN AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 283 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 284 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 285 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 287 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE,2022–2029 (USD MILLION)
  • TABLE 288 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 289 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 290 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 291 MIDDLE EAST & AFRICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 292 MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 293 GCC COUNTRIES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 294 GCC COUNTRIES: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 295 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 296 GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 297 GCC COUNTRIES: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 298 GCC COUNTRIES: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 299 GCC COUNTRIES: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 300 GCC COUNTRIES: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 301 GCC COUNTRIES: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 302 REST OF MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)
  • TABLE 303 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 304 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 305 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 306 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 307 REST OF MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 308 REST OF MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 309 REST OF MIDDLE EAST & AFRICA: OTHER INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 REST OF MIDDLE EAST & AFRICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 311 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 312 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 313 REGION FOOTPRINT
  • TABLE 314 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: PRODUCT FOOTPRINT
  • TABLE 315 ANGIOPLASTY STENTS FOOTPRINT
  • TABLE 316 STRUCTURAL HEART DEVICES FOOTPRINT
  • TABLE 317 CATHETERS FOOTPRINT
  • TABLE 318 ANGIOPLASTY BALLOONS FOOTPRINT
  • TABLE 319 PLAQUE MODIFICATION DEVICES FOOTPRINT
  • TABLE 320 HEMODYNAMIC FLOW ALTERATION DEVICES FOOTPRINT
  • TABLE 321 OTHER INTERVENTIONAL CARDIOLOGY DEVICES FOOTPRINT
  • TABLE 322 END-USER FOOTPRINT
  • TABLE 323 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 324 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 325 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 326 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 327 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: EXPANSIONS, JANUARY 2021–OCTOBER 2024
  • TABLE 328 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 329 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 330 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 331 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 332 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 333 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 334 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–OCTOBER 2024
  • TABLE 335 MEDTRONIC: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 336 ABBOTT: COMPANY OVERVIEW
  • TABLE 337 ABBOTT: PRODUCTS OFFERED
  • TABLE 338 ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 339 ABBOTT: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 340 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 341 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 342 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 343 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 344 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 345 TERUMO CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2024
  • TABLE 346 TERUMO CORPORATION.: EXPANSIONS, JANUARY 2021−OCTOBER 2024
  • TABLE 347 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 348 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 349 EDWARDS LIFESCIENCES CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 350 EDWARDS LIFESCIENCES CORPORATION: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 351 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 352 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 353 B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 354 B. BRAUN SE: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 355 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 356 INTEGER HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 357 INTEGER HOLDINGS CORPORATION.: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 358 INTEGER HOLDINGS CORPORATION: EXPANSIONS, JANUARY 2021−OCTOBER 2024
  • TABLE 359 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 360 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 361 TELEFLEX INCORPORATED: PRODUCT APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 362 PENUMBRA, INC.: COMPANY OVERVIEW
  • TABLE 363 PENUMBRA, INC: PRODUCTS OFFERED
  • TABLE 364 PENUMBRA, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 365 COOK: COMPANY OVERVIEW
  • TABLE 366 COOK: PRODUCTS OFFERED
  • TABLE 367 COOK: DEALS, JANUARY 2021–OCTOBER 2024
  • TABLE 368 CORDIS: COMPANY OVERVIEW
  • TABLE 369 CORDIS.: PRODUCTS OFFERED
  • TABLE 370 CORDIS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−OCTOBER 2024
  • TABLE 371 CORDIS: DEALS, JANUARY 2021−OCTOBER 2024
  • TABLE 372 IVASCULAR S.L.U.: COMPANY OVERVIEW
  • TABLE 373 IVASCULAR S.L.U: PRODUCTS OFFERED
  • TABLE 374 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW
  • TABLE 375 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS OFFERED
  • TABLE 376 BIOSENSORS INTERNATIONAL GROUP, LTD: PRODUCT LAUNCHES, JANUARY 2021−OCTOBER 2024
  • TABLE 377 BIOTRONIK SE & CO. KG: COMPANY OVERVIEW
  • TABLE 378 BIOTRONIK SE & CO. KG: PRODUCTS OFFERED
  • TABLE 379 BIOTRONIK SE & CO. KG: PRODUCT LAUNCHES, JANUARY 2021−OCTOBER 2024
LIST OF FIGURES
 
  • FIGURE 1 INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND OTHER PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC (2023)
  • FIGURE 9 TOP-DOWN APPROACH
  • FIGURE 10 SUPPLY-SIDE ANALYSIS: INTERVENTIONAL CARDIOLOGY DEVICES MARKET (2023)
  • FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 12 CAGR PROJECTIONS
  • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 ANGIOPLASTY STENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 STRUCTURAL HEART DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 CATHETERS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 20 OTHER DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 21 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 22 GEOGRAPHIC SNAPSHOT OF INTERVENTIONAL CARDIOLOGY DEVICES MARKET
  • FIGURE 23 INCREASING PREVALENCE OF CVD AND DIABETES TO PROPEL MARKET
  • FIGURE 24 HOSPITALS ACCOUNTED FOR LARGEST MARKET SHARE IN CHINA FOR 2023
  • FIGURE 25 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 26 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 27 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 28 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 31 INDICATIVE AVERAGE SELLING PRICE TREND OF INTERVENTIONAL CARDIOLOGY DEVICES, BY PRODUCT TYPE, 2023
  • FIGURE 32 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: ECOSYSTEM MAP
  • FIGURE 33 PATENT PUBLICATION TRENDS (JANUARY 2013–OCTOBER 2024)
  • FIGURE 34 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INTERVENTIONAL CARDIOLOGY DEVICES PATENTS (JANUARY 2013–OCTOBER 2024)
  • FIGURE 35 TOP APPLICANT COUNTRIES/REGIONS FOR INTERVENTIONAL CARDIOLOGY DEVICES PATENTS (JANUARY 2013–OCTOBER 2024)
  • FIGURE 36 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 END USERS
  • FIGURE 37 KEY BUYING CRITERIA FOR TOP 3 END USERS
  • FIGURE 38 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN INTERVENTIONAL CARDIOLOGY DEVICES MARKET
  • FIGURE 39 INTERVENTIONAL CARDIOLOGY DEVICES: ADJACENT MARKETS
  • FIGURE 40 INVESTMENT/VENTURE CAPITAL SCENARIO IN INTERVENTIONAL CARDIOLOGY DEVICES MARKET, 2019–2024
  • FIGURE 41 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: GEOGRAPHIC SNAPSHOT (2023)
  • FIGURE 42 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT
  • FIGURE 43 ASIA PACIFIC: INTERVENTIONAL CARDIOLOGY DEVICES MARKET SNAPSHOT
  • FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS IN INTERVENTIONAL CARDIOLOGY DEVICES MARKET (2019−2023)
  • FIGURE 45 MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • FIGURE 46 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 47 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 48 INTERVENTIONAL CARDIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 49 EV/EBITDA OF KEY VENDORS
  • FIGURE 50 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 51 INTERVENTIONAL CARDIOLOGY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 52 R&D ASSESSMENT OF KEY PLAYERS IN INTERVENTIONAL CARDIOLOGY DEVICES MARKET, 2021–2023
  • FIGURE 53 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT (2023)
  • FIGURE 55 ABBOTT: COMPANY SNAPSHOT (2023)
  • FIGURE 56 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
  • FIGURE 57 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 58 EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 59 B. BRAUN SE: COMPANY SNAPSHOT (2023)
  • FIGURE 60 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 61 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 62 PENUMBRA, INC.: COMPANY SNAPSHOT (2023)

This study involved four major activities in estimating the size of the interventional cardiology devices market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the interventional cardiology devices market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the interventional cardiology devices market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

Breakdown of Primary Interviews

Interventional Cardiology Devices Market

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include Others include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the interventional cardiology devices market includes the following details. The market sizing of the market was undertaken from the global side.

Country-level Analysis: The size of the interventional cardiology devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall interventional cardiology devices market was obtained from secondary data and validated by primary participants to arrive at the total interventional cardiology devices market. Primary participants further validated the numbers.

Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall interventional cardiology devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Interventional cardiology devices Size: Top-Down and Bottom Up Approach

Interventional Cardiology Devices Market

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

The interventional cardiology devices market encompasses medical devices used in minimally invasive procedures for diagnosing and treating cardiovascular conditions, particularly those involving the coronary arteries and heart valves. This market includes a range of devices such as stents, balloons, catheters, guidewires, and other adjunctive equipment essential for procedures like angioplasty, atherectomy, and transcatheter valve replacements.

Stakeholders

  • Manufacturers of interventional cardiology devices
  • Interventional cardiology device distributors
  • Healthcare service providers
  • Various research associations related to interventional cardiology devices
  • Research institutes
  • Venture capitalists and investors
  • Various research and consulting companies
  • World Health Organization (WHO)
  • Organization for Economic Co-operation and Development (OECD)
  • National Institutes of Health (NIH)
  • Centers for Disease Control and Prevention (CDC)
  • Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
  • White Papers, Journals/Magazines, and News Articles
  • Paid Databases, such as Factiva, D&B Hoovers, and Bloomberg Business

Report Objectives

  • To define, describe, segment, and forecast the interventional cardiology devices market by angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices & end user, and region
  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall interventional cardiology devices market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the interventional cardiology devices market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the interventional cardiology devices market and comprehensively analyze their core competencies2 and market shares
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the interventional cardiology devices market
  • To benchmark players within the interventional cardiology devices market using the competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

Previous Versions of this Report

Interventional Cardiology Devices Market by type (Stents, Structural Heart, Catheters, Plaque Modification (Atherectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath, IVUS)) - Global Forecast to 2025

Report Code MD 3456
Published in Jan, 2021, By MarketsandMarkets™

Interventional Cardiology Devices Market by type (Angioplasty, Catheters, Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection, Total Occlusion), Guidewire, Introducer Sheath)) - Global Forecast to 2022

Report Code MD 3456
Published in Dec, 2017, By MarketsandMarkets™

Interventional Cardiology & Peripheral Vascular Devices Market (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts to 2021

Report Code MD 3456
Published in Dec, 2016, By MarketsandMarkets™

Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019

Report Code MD 3456
Published in Jun, 2015, By MarketsandMarkets™

Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019

Report Code MD 3456
Published in Feb, 2012, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.

By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Interventional Cardiology Devices Market

Siri

May, 2022

what are the growth opportunities in interventional cardiovascular devices market.

Benjamin

Mar, 2022

Looking forward to gain more insights on the global Interventional Cardiology Devices Market.

Samuel

Mar, 2022

Can you enlighten us on geographical growth analysis in Interventional Cardiology Devices Market?.

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status